Purchase Order 36C26326P0418
- Not listed
- Edwards Lifesciences LLC, a leading cardiovascular medical device manufacturer and self-certified small disadvantaged business, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, Minnesota) for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies. The award, issued on March 27, 2026, with an ultimate completion date of April 26, 2026, represents a non-set-aside procurement reflecting Edwards...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from the Department of Veterans Affairs' Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on February 6, 2026, with a completion date of February 9, 2026, reflects no set-aside designation and represents a typical procurement structure...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis VA) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of January 20, 2026. This contract, awarded on January 16, 2026, carries no set-aside designation and represents Edwards Lifesciences' specialized supply of advanced cardiovascular medical devices to the Department of Veterans Affairs. The award is structured as a...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of April 6, 2026. The contract was awarded without a set-aside designation on April 3, 2026. This purchase order falls within Edwards Lifesciences LLC's broader framework relationship with the Department of Veterans Affairs, where the company serves as a primary...
- Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of May 24, 2026. The contract, which carries no set-aside designation, represents a continuation of Edwards Lifesciences' extensive supply relationship with the Department of Veterans Affairs. The award supports VISN 23's cardiac surgical programs by providing...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation specializing in advanced cardiovascular medical devices, was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) on March 13, 2026, with an ultimate completion date of March 16, 2026. The contract, which carries no set-aside designation, is for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies to support the Department of...
- Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems. The award, issued on March 20, 2026, with an ultimate completion date of March 23, 2026, reflects the VA's critical need for specialized cardiovascular medical devices to support cardiac surgical programs...
- Edwards Lifesciences LLC was awarded a $34K firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of March 3, 2026. This award carries no set-aside designation and represents a direct procurement of specialized cardiovascular medical devices essential to the Department of Veterans Affairs' cardiac care mission. The contract reflects Edwards Lifesciences' established...
- Edwards Lifesciences LLC was awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network (VISN) 23 on January 12, 2026, for transcatheter aortic valve replacement (TAVR) medical devices. The contract, which carries no set-aside designation, is scheduled for completion by February 11, 2026, with performance taking place in Minneapolis, Minnesota. As a subsidiary of Edwards Lifesciences Corporation, a global leader in structural heart disease treatment, the...
- The Department of Veterans Affairs, Veterans Integrated Service Network 23 (Minneapolis) awarded a $34,000 firm fixed-price purchase order to Edwards Lifesciences LLC for transcatheter aortic valve replacement (TAVR) systems on April 3, 2026, with an ultimate completion date of April 6, 2026. This contract was awarded without a set-aside designation and represents a direct procurement of specialized cardiovascular medical devices essential to the VA's cardiac surgical programs. Edwards...
Edwards Lifesciences LLC received a $34,000 firm fixed-price purchase order from Veterans Integrated Service Network 23 (Minneapolis, MN) for transcatheter aortic valve replacement (TAVR) systems, with an ultimate completion date of April 27, 2026. The award was issued without a set-aside designation on April 24, 2026, and represents a standalone purchase order for specialized cardiovascular medical devices. Edwards Lifesciences LLC, a subsidiary of Edwards Lifesciences Corporation and self-certified small disadvantaged business, is a leading supplier of advanced cardiac technologies to the Department of Veterans Affairs, specializing in transcatheter heart valves and surgical implants essential to the VA's cardiac surgical programs. This purchase order aligns with Edwards Lifesciences LLC's extensive contracting relationship with the VA system, which includes over 200 prime federal contract awards distributed across multiple Veterans Integrated Service Networks since 2025, predominantly for TAVR and related cardiovascular devices. The company maintains two significant indefinite delivery contracts with the VA totaling $7.45 million in ceiling value—a $6.5 million five-year consignment services agreement with VISN 21 (effective through December 31, 2030) and a $950,000 five-year agreement with VISN 15 (effective through October 19, 2030)—which provide long-term frameworks for ensuring consistent availability of specialized surgical implants and transcatheter heart valves across multiple VA service networks to support veteran cardiac care outcomes.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6515--PROS V23 618 UNU BILL & REPLACE 6183080357 (MI) TAVR (NEED ON OR BEFORE 04/28/2026) (VA-26-00063950) | 36C26326Q0617 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 | Award Notice 1/1 | 4/24/26, 2:44 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.0k | 4/23/26 |